NIH awarding $20B in HIT contracts

The National Institutes of Health's Information Technology Acquisition and Assessment Center is awarding $20 billion in IT work including deployment and installation, maintenance and training, engineering studies, enterprise licenses and extended warranties, everything-as-a-service, mobility, collaboration, web and video-conferencing, cyber security, big data, virtualization and health and biomedical IT.

The money will be disbursed among 65 companies across the country, including 44 small businesses.

All those awarded through the government-wide acquistion contract (GWAC) went through a competitive source selection process to ensure the most technically capable and competitively priced solutions will be available over the next 10 years, according to NIH.

CIO-CS follows the awards of the CIO-SP3.

"Our vision was to create a strong suite of contracts which meet the IT needs of not only NIH but the entire federal landscape," Diane J. Frasier, director of the Office of Acquisition and Logistics Management and head of the contracting activity at NIH, said in a statement.

"With its emphasis on cloud and managed services, we expect CIO-CS to appeal to a broad base of customers throughout the government tasked with implementing IT solutions," added Brian Goodger, associate director of the NIH Office of Acquisitions and Logistics Management.

"We will continue to build strong relationships with our customers through superior customer service and quality contracting," added Robert Coen, NITAAC program director, in a statement. The contract, he said, "introduces a new, highly select community now poised to serve the federal government's emerging, next generation information technology needs within a culture that embraces uncompromising quality and bold innovation."

See the list of selected companies.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.